Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
NuvOx Pharma
company
About
NuvOx Pharma is developing a nanotechnology for oxygen delivery, DDFPe, which is a best-in-class drug that is Phase II ready in stroke.
- 11 - 50
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $2M
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2008
- Number Of Employee
- 11 - 50
- Operating Status
- Active
NuvOx Pharma is developing a is developing a platform of drugs that, upon intravenous injection, flow through the bloodstream arriving first at the lungs to pick up oxygen and finally to hypoxic tissue where they passively deliver the oxygen. Indications for NuvOx's drug include Stroke (Phase II ready), Oncology (Phase II ready), and Sickle Cell Crisis (Phase Ib ready).
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$2.30M
NuvOx Pharma has raised a total of
$2.30M
in funding over 2 rounds. Their latest funding was raised on
Jul 14, 2018 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 14, 2018 | Grant | $2M | 1 |
National Institutes of Health
|
— | Detail |
| Nov 1, 2016 | Grant | $300K | 1 |
National Institutes of Health
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
1
NuvOx Pharma is funded by 1 investors.
National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Institutes of Health
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
